279-490-5

应用筛选条件

关键词:'279-490-5'

显示 1-14 共 14 条结果关于 "279-490-5" 范围技术文档

Quality Control Range Sheet- MCKP1-102 and MCKP1-202

Galectin-1 Control1 36 - 75 pg/ml Control 2 134 - 279 pg/ml Galectin-3 Control1 325 - 676 pg/ml Control 2 1248 - 2591 pg/ml

XP725 Antibody Number-Lot Number 071M4826

531 532 553 554 555 556 6.2 485 486 487 488 509 510 511 512 533 534 535 536 557 558 559 560 6.3 489 490 491 492 513 514 515 516 537 538 539 540 561 562 563 564 6.4 493 494

Anti-NeuN, clone A60 - Data Sheet

Scheffler, B., et al., PNAS (2005) 102:9353-9358. 69) Yang, P., et al., J. Comparative Neurology (2005) 490:163-179. 70) Sasaki, T., et al., Stroke (2005) 36:2457-2462. 71) Cummings, B., et al., PNAS (2005

Apoptosis - Antibodies, Reagents and Kits

, clone 5G3 H M WB M 100 µL 05-941 $279 Anti-PP2A, A subunit, clone 4G7 H M R Xn WB M IgG1 200 µg 05-657 $329 PP2A Cα subunit SMARTpool siRNA reagent H RNAi 5 nmol

PKH Dye Reference Guide

Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol. 1990; 33: 469-90: 469-490. 186. Jensen B, Schmitt T, Slezak S: Labeling of Mammalian Cells for In-Vivo Cell Tracking

XP725 Antibody List Lot 129K4831

Factor-9 F1672 2254 FGF9 M NP_002001.1 y y n/d 283 FOXC2 F1054 2303 FOXC2 P NP_005242.1 y y n/d 279 FKHR (FOXO1a) F6928 2308 FOXO1 M NP_002006.2 y n/d n/d 280 FKHRL1 (FOXO3a) F2178 2309 FOXO3 P NP_001446.1

XP725 Antibody List Lot 129K4830

XP725 Antibody List Lot 089K4791

Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d 488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2 y n/d y 490 Nedd 8 N2786 4738 NEDD8 M NP_006147.1 y n/d n/d 498 Neurofilament 160 N2787 4741 NEFM M NP_001099011.1

XP725 Worksheet for Lot Number 071M4826

bCatenin C7082 277 2 2 5 5 bCatenin pThr41 C8616 278 2 2 5 6 bCatenin pThr41 C8616 279 2 2 5 7 b Catenin pSer33pSer37 C4231 280 2 2 5 8 bCatenin pSer33pSer37 C4231 281 2 2 6 1 phospho-b-Catenin pSer45 C5615

List of Antibodies

n/d 276 Fibronectin F7387 M y y n/d 277 Filamin F1888 M n/d n/d n/d 278 Filensin F1043 M y y n/d 279 FKHR (FOXO1a) F6928 M y n/d n/d 280 FKHRL1 (FOXO3a) F2178 P y y n/d 281 FKHRL1 (FOXO3a) F1304 M y

Halal Certificate

22SI5413 278. 4-Hydroxy-4-Methyl-7-cis-Decenoic Acid L-Lactone W393713 C41924 HC-22SIDA11 279. 4-HYDROXY-5-METHYL-3-FURANONE 97%, FG W363501 A88716 HC-22SI8C64 280. 4-HYDROXYBENZALDEHYDE 97%, FG W398403

Halal Certificate

23SIE791 278. 4-Hydroxy-4-Methyl-7-cis-Decenoic Acid L-Lactone W393713 C41924 HC-23SIJT89 279. 4-HYDROXY-5-METHYL-3-FURANONE 97%, FG W363501 A88716 HC-23SILS43 280. 4-HYDROXYBENZALDEHYDE 97%, FG W398403

XP725 Antibody List 013M4793

277 Filamin F1888 395260 LOC395260 M n/d n/d n/d 278 Filensin F1043 631 BFSP1 NP_001186.1 M y y n/d 279 FKHR (FOXO1a) F6928 2308 FOXO1A NP_002006.2 M y n/d n/d 280 FKHRL1 (FOXO3a) F2178 2309, 56484 Foxo3a

XP725 Antibody List

.2 P y n/d y 489 Nck-2 N2911 316369, 8440 NCK2,Nck2_predicted NP_001101686.1,NP_003572.2 M y n/d y 490 Nedd 8 N2786 4738 NEDD8 NP_006147.1 M y n/d n/d 491 Nerve Growth Factor-β N3279 18049, 4803 NGFB